- Previous Close
0.8300 - Open
0.8300 - Bid 0.5100 x --
- Ask 0.8299 x 40000
- Day's Range
0.8300 - 0.8300 - 52 Week Range
0.2300 - 1.1500 - Volume
100 - Avg. Volume
266 - Market Cap (intraday)
39.65M - Beta (5Y Monthly) -1.19
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HST Global, Inc., operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases. HST Global, Inc. was incorporated in 2004 and is headquartered in Virginia Beach, Virginia.
www.hstglobal.comRecent News: HSTC
View MorePerformance Overview: HSTC
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSTC
View MoreValuation Measures
Market Cap
39.65M
Enterprise Value
39.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
32.00
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-9.56%
Return on Equity (ttm)
-29.69%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-101.51k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
10.41k
Total Debt/Equity (mrq)
3.36%
Levered Free Cash Flow (ttm)
-526.82k